Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(898/week)
    • Manufacturing(434/week)
    • Technology(914/week)
    • Energy(322/week)
    • Other Manufacturing(289/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Amgen

May 16, 2025
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
May 01, 2025
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Apr 28, 2025
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
Apr 11, 2025
IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER
Apr 03, 2025
UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE
Mar 13, 2025
UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS
Mar 08, 2025
AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Mar 04, 2025
AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND
Feb 07, 2025
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
Jan 31, 2025
AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
Jan 08, 2025
AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Nov 29, 2024
AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
Nov 26, 2024
AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM
Nov 13, 2024
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
Nov 08, 2024
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
Nov 08, 2024
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Oct 01, 2024
LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
Sep 24, 2024
TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE
Sep 23, 2024
AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE
Sep 09, 2024
AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA(TM) (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024
  •  
  • Page 1
  • ››

Latest News

May 30, 2025

Faraday Future Secures Binding Deposit for 600 FX Super One MPV from New PBB Auto, and is Also Exploring a...

May 30, 2025

Tamboran announces successful closing of First Tranche of PIPE

May 30, 2025

Northrop Grumman Invests $50 Million in Firefly Aerospace to Advance Eclipse™ Medium Launch Vehicle

May 30, 2025

Patria to begin assembly of ASCOD Infantry Fighting Vehicles in Latvia

May 30, 2025

U.S. Space & Rocket Center holds Blue Origin flight launch party

May 30, 2025

Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy...

May 30, 2025

Laser Photonics Received NASDAQ Notice of Delisting for Failure to Satisfy a Continued Listing Rule or...

May 30, 2025

JETOUR Achieves No.1 Sales Among Chinese Brands in Middle East from January to April 2025

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Seabed Security (30 September - 01 October 2025 in...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia